Suppr超能文献

非接触式低频超声疗法在分子水平上是否有助于伤口愈合?

Does noncontact low-frequency ultrasound therapy contribute to wound healing at the molecular level?

作者信息

Wiegand Cornelia, Bittenger Kyle, Galiano Robert D, Driver Vickie R, Gibbons Gary W

机构信息

Department of Dermatology, University Hospital Jena, Jena, Germany.

Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

出版信息

Wound Repair Regen. 2017 Sep;25(5):871-882. doi: 10.1111/wrr.12595. Epub 2017 Dec 8.

Abstract

Noncontact low-frequency ultrasound (NLFU) is used to treat various types of chronic wounds including venous, diabetic, and pressure ulcers. The objective for this substudy of the IN BALANCE RCT VLU trial was to characterize and compare the NLFU treatment group and patients receiving standard of care (SOC) with respect to the effect of the assigned study treatment on content/quantity of inflammatory cytokines and fibrinogen as well as bacteria. Higher mean wound area reduction was observed in the NLFU treatment group (67.0%) compared to the SOC group (41.6%, p < 0.05). Hypertension, diabetes type II, coronary artery disease, and anemia were identified as the most common comorbidities of the Chronic venous leg ulcer (CVLU) patients included in the study. Pseudomonas, Corynebacterium, and unclassified Enterobacteriaceae were dominant in the highest number of samples. Anaerococcus, Peptoniphilus, and Finegoldia, had the highest median proportion in the samples overall. Peptoniphilus abundance decreased more in the NLFU treatment group relative to SOC; similar trends were observed for Anaerococcus and Finegoldia. Progression of mediators like TNF-alpha, IL-1beta, IL-6, IL-8, and IL-10 as well as PF4, TGF-beta, and fibrinogen was monitored and trends for several of the mediators were identified. Fibrinogen amounts were significantly reduced over time in the NLFU treatment group (p < 0.05). IL-8 levels declined in wound fluid from NLFU responders as well as SOC responders. Bacterial load (total bacterial abundance) determined local parameters of ulcer inflammation. If a bioburden of ≥ 10E was found compared to < 10E , levels of IL-1beta, IL-8, and TNF-alpha were significantly higher. In conclusion, NLFU treatment is an effective adjuvant tool for CVLU therapy. This study demonstrates that it improves wound healing by equally inhibiting abundant levels of pro-inflammatory cytokines as well as by reducing the overall bacterial burden.

摘要

非接触式低频超声(NLFU)用于治疗各种类型的慢性伤口,包括静脉性、糖尿病性和压疮。IN BALANCE RCT VLU试验的这项子研究的目的是,就指定研究治疗对炎性细胞因子和纤维蛋白原的含量/数量以及细菌的影响,对NLFU治疗组和接受标准护理(SOC)的患者进行特征描述和比较。与SOC组(41.6%,p < 0.05)相比,NLFU治疗组观察到更高的平均伤口面积减少率(67.0%)。高血压、II型糖尿病、冠状动脉疾病和贫血被确定为该研究纳入的慢性下肢静脉溃疡(CVLU)患者最常见的合并症。铜绿假单胞菌、棒状杆菌和未分类的肠杆菌科在数量最多的样本中占主导地位。厌氧球菌、消化链球菌和菲氏菌在总体样本中的中位数比例最高。相对于SOC,NLFU治疗组中消化链球菌的丰度下降得更多;厌氧球菌和菲氏菌也观察到类似趋势。监测了肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6、白细胞介素-8和白细胞介素-10以及血小板因子4、转化生长因子-β和纤维蛋白原等介质的变化,并确定了其中几种介质的变化趋势。NLFU治疗组中纤维蛋白原含量随时间显著降低(p < 0.05)。NLFU反应者和SOC反应者伤口液中的白细胞介素-8水平均下降细菌载量(总细菌丰度)决定了溃疡炎症的局部参数。如果发现生物负荷≥10E,而<10E,则白细胞介素-1β、白细胞介素-8和肿瘤坏死因子-α的水平显著更高。总之,NLFU治疗是CVLU治疗的一种有效辅助工具。这项研究表明,它通过同等程度地抑制大量促炎细胞因子以及减少总体细菌负荷来促进伤口愈合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验